A citation-based method for searching scientific literature

Julie B Hjerpsted, Anne Flint, Ashley Brooks, Mads B Axelsen, Trine Kvist, John Blundell. Diabetes Obes Metab 2018
Times Cited: 49



Adrian F Hernandez, Jennifer B Green, Salim Janmohamed, Ralph B D'Agostino, Christopher B Granger, Nigel P Jones, Lawrence A Leiter, Anne E Rosenberg, Kristina N Sigmon, Matthew C Somerville, Karl M Thorpe, John J V McMurray, Stefano Del Prato. Lancet 2018
Times Cited: 607




List of shared articles



Times cited

Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists.
Michael P Kane, Curtis L Triplitt, Carolina D Solis-Herrera. Am J Health Syst Pharm 2021
1

The Discovery and Development of Liraglutide and Semaglutide.
Lotte Bjerre Knudsen, Jesper Lau. Front Endocrinol (Lausanne) 2019
106



Insights into incretin-based therapies for treatment of diabetic dyslipidemia.
Kerstin Stemmer, Brian Finan, Richard D DiMarchi, Matthias H Tschöp, Timo D Müller. Adv Drug Deliv Rev 2020
6

Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease prevention.
Emir Muzurović, Siniša Dragnić, Sanja Medenica, Brigita Smolović, Predrag Bulajić, Dimitri P Mikhailidis. J Diabetes Complications 2020
5

Lipid effects of glucagon-like peptide 1 receptor analogs.
Amanda J Berberich, Robert A Hegele. Curr Opin Lipidol 2021
0


GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
Andrei C Sposito, Otávio Berwanger, Luiz Sérgio F de Carvalho, José Francisco Kerr Saraiva. Cardiovasc Diabetol 2018
50